Title:
INTERLEUKIN-2 GENE TRANSFERRED LYMPHOKINE ACTIVATED KILLER CELLS
Document Type and Number:
WIPO Patent Application WO2003044183
Kind Code:
A8
Abstract:
The present invention relates to a transformed lymphokine activated killer cell (I-LAK cell) useful in the treatment of cancer or virus infection into which a recombinant vector carrying IL-2 gene to which it is operably linked is introduced. Also it relates to a pharmaceutical composition for treating cancer or virus infection disease comprising a sufficient amount of I-LAK cell to elicit an immune response.
Inventors:
YOO NAE-CHOON (KR)
CHANG KYUNG-HEE (KR)
KIM YEON-SOO (KR)
KIM JUNE-MYUNG (KR)
CHANG KYUNG-HEE (KR)
KIM YEON-SOO (KR)
KIM JUNE-MYUNG (KR)
Application Number:
PCT/KR2002/002196
Publication Date:
May 27, 2004
Filing Date:
November 22, 2002
Export Citation:
Assignee:
MEDIGENES (KR)
YOO NAE-CHOON (KR)
CHANG KYUNG-HEE (KR)
KIM YEON-SOO (KR)
KIM JUNE-MYUNG (KR)
YOO NAE-CHOON (KR)
CHANG KYUNG-HEE (KR)
KIM YEON-SOO (KR)
KIM JUNE-MYUNG (KR)
International Classes:
C12N15/09; A61K35/14; A61K35/76; A61K39/00; A61P31/12; A61P31/18; A61P35/00; C12N5/0783; C12N5/10; C12N5/22; (IPC1-7): C12N5/22
Download PDF:
Previous Patent: CELLS EXPRESSING gob−5 AND USE THEREOF
Next Patent: PURIFIED POLYPEPTIDES INVOLVED IN GENERAL METABOLISM
Next Patent: PURIFIED POLYPEPTIDES INVOLVED IN GENERAL METABOLISM